6-Formyl-2-methylsulfanyl-nicotinonitrile, 95.0%, 1g

Tert-butyl3-(5-bromopentoxy)azetidine-1-carboxylate, 98%, 250mg

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

2-Bromo-6-(1H-imidazol-1-yl)pyridine, 95+%, 250mg

2-(4-Methylpyridin-2-yl)acetonitrile, 95+%, 1g

Rotilabo®-Stativdreifuß, Stahl, Gewindebohrung M 10, Schenkellänge 80 mm, 1 Stück

5-Phenyl-1H-indole, 95.0%, 1g

1-(1-Isopropyl-1H-pyrrolo[2,3-c]pyridin-3-yl)ethanone, 95.0%, 2g

BRIVANIB ALANINATE, 95%, 25mg

2-(7,8-Difluoronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

2-Oxaspiro[3.3]heptan-6-ylmethanol, 95.0%, 1g

Ethyl 2,4-dioxohexanoate, 95.0%, 1g

N-(Pyridin-4-yl)acetamide, 95.0%, 1g